LETTER TO THE EDITOR
Treatment of chronic hepatitis C with pegylated interferon-α in a patient with recurrent autoimmune thrombotic thrombocytopenic purpura
Article first published online: 29 OCT 2012
© 2012 The Authors. Transfusion Medicine © 2012 British Blood Transfusion Society
Volume 23, Issue 1, pages 66–68, February 2013
How to Cite
Lotta, L. A., Degasperi, E., Aghemo, A., Ferrari, B., Peyvandi, F. and Colombo, M. (2013), Treatment of chronic hepatitis C with pegylated interferon-α in a patient with recurrent autoimmune thrombotic thrombocytopenic purpura. Transfusion Medicine, 23: 66–68. doi: 10.1111/j.1365-3148.2012.01197.x
- Issue published online: 22 JAN 2013
- Article first published online: 29 OCT 2012
- Manuscript Accepted: 20 SEP 2012
- Manuscript Revised: 6 SEP 2012
- Manuscript Received: 13 JUN 2012
- Italian Ministry of Health. Grant Number: 2009-1530493
- Fondazione Cariplo. Grant Number: 2011-0524
Options for accessing this content:
- If you have access to this content through a society membership, please first log in to your society website.
- If you would like institutional access to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
- New Users: Please register, then proceed to purchase the article.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!
Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.